Solu-Medrol powder lyophilized for solution for i/m and i/v injection

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

methylprednisolone (methylprednisolone sodium succinate)

Доступна с:

Pfizer Manufacturing Belgium N.V.

код АТС:

H02AB04

ИНН (Международная Имя):

methylprednisolone (methylprednisolone sodium succinate)

дозировка:

500mg

Фармацевтическая форма:

powder lyophilized for solution for i/m and i/v injection

Штук в упаковке:

(1) glass vial with powder and (1) glass vial with solvent 7,8ml

Тип рецепта:

Prescription

Статус Авторизация:

Registered

Дата Авторизация:

2016-10-17

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
SOLU-MEDROL
METHYLPREDNISOLONE SODIUM SUCCINATE
1.
NAME OF THE MEDICINAL PRODUCT
SOLU-MEDROL
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active _ingredient — _methylprednisolone (in the form of
methylprednisolone sodium succinate)
40 mg, 125 mg, 250 mg, 500 mg, 1000 mg;
Excipients see section 6.1
3.
PHARMACEUTICAL FORM
Sterile powder for injection.
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Solu-Medrol is indicated in_ _the following conditions:
ENDOCRINE DISORDERS
1

primary or secondary adrenocortical insufficiency (in conjunction with
mineralocorticoids,
where applicable)

acute adrenocortical insufficiency (mineralocorticoid supplementation
may be necessary)

shock secondary to adrenocortical insufficiency, or shock unresponsive
to conventional
therapy when adrenal cortical insufficiency may be present (when
mineralocorticoid activity
is undesirable)
1,2
_ _

preoperatively, or in the event of serious trauma or illness, in
patients with known adrenal
insufficiency or when adrenocortical reserve is doubtful

congenital adrenal hyperplasia

nonsuppurative thyroiditis

hypercalcemia associated with cancer.
RHEUMATIC DISORDERS
1,2
(as adjunctive therapy for short-term administration in the management
of an acute episode or exacerbation)_ _

post-traumatic osteoarthritis

synovitis of osteoarthritis

rheumatoid arthritis, including juvenile rheumatoid arthritis

acute and subacute bursitis

epicondylitis

acute nonspecific tenosynovitis

acute gouty arthritis

psoriatic arthritis

ankylosing spondylitis.
COLLAGEN DISEASES AND IMMUNE COMPLEX DISEASES_ _(during an
exacerbation or as maintenance
therapy in selected cases)

systemic lupus erythematosus (and lupus nephritis)

acute rheumatic carditis

systemic dermatomyositis (polymyositis)

polyarteritis nodosa

Goodpasture's syndrome.
DERMATOLOGIC DISEASES_ _

pemphigus

severe erythema multiforme (Stevens-Johnson syndrome)

exfoliative dermatitis
�